The ProShares Ultra Ether ETF (ETHT), a 2x daily leveraged Ethereum fund, has rebounded about 45% since late June as Ethereum recovered above $1,500. This ETF is designed for short-term tactical exposure rather than long-term holding due to risks from volatility and daily compounding effects, which can cause returns to diverge significantly from 2x Ethereum's actual performance. The sharp decline from February to June highlights these risks. The analyst recommends waiting for ETHT to surpass $11.37 and Ethereum to break above $2,000 with confirmation before considering a tactical investment, rating ETHT as a Hold for now.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...
SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...
Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...
Citigroup reaffirmed its Buy rating on NIO but lowered the price target from $8.20 to $7.10 due to NIO's second-quarter deliveries and revenue missing company guidance and a third-quarter outlook below Wall Street estimates. Despite a 49.4% year-over...
